A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT04714320
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT04714320
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT04714320. Randomized; no masking; primary purpose treatment. Start 2021-04-28 (actual); primary completion 2022-06-29 (actual). Results posted on 2025-02-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure
- Acronym
- ASTRAAS
- Condition
- Hypertension
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- IONIS-AGT-LRx
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct04714320- Content hash
65b5de0eab25877ae82cf9bc789d3cb992906f7b538f166ec03937d8ea5aaad2